Richard A. Young - 15 Oct 2024 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Reporting relationship: Director
Issuer ticker: CAMP
Reported as of: 15 Oct 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Oct 2024, 17:46:10 UTC
Prior SEC filing: 10 Oct 2024
Next SEC filing: 27 Jun 2025
Source filing: View source filing
Reporting owner signature: By: /s/ Thomas Danielski, Attorney-in-Fact

Key filing fact

Richard A. Young filed Form 4 for Camp4 Therapeutics Corp (CAMP) on 15 Oct 2024.

Key facts

This page summarizes Richard A. Young's Form 4 filing for Camp4 Therapeutics Corp (CAMP).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Oct 2024, 17:46.

Change

Previous filing in this sequence was filed on 10 Oct 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAMP transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +8,917
Change %: +6.1%
Price
Shares after: 154,859
Date: 15 Oct 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CAMP transaction Derivative

Series A Prime Preferred Stock

Conversion of derivative security

Transaction value
Shares: -100,014
Change %: -100%
Price
Shares after: 0
Date: 15 Oct 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,917
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-1 basis without payment of further consideration upon the closing of the Issuer's initial public offering.